EGAS00001005559-sc-2022-10-13T09:15:05Z - samples

ABSTRACT: Mesothelioma is an aggressive cancer associated with previous exposure to asbestos and dismal prognosis. Since a pemetrexed/cisplatin combination was introduced for treatment of mesothelioma, no new first- or second-line therapies have been discovered. Thus, to better understand what drives mesothelioma carcinogenesis and to identify potential targets for therapy, in this project we aim at performing WGS analysis of a panel of mesothelioma cells lines.

PROVIDER: EGAD00001009641 | EGA |

REPOSITORIES: EGA